Inhibition of serine/arginine-rich protein kinase-1 (SRPK1) prevents cholangiocarcinoma cells induced angiogenesis.
Toxicol In Vitro
; 82: 105385, 2022 Aug.
Article
in En
| MEDLINE
| ID: mdl-35568131
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Protein Serine-Threonine Kinases
/
Cholangiocarcinoma
Limits:
Humans
Language:
En
Journal:
Toxicol In Vitro
Journal subject:
TOXICOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: